Iterum Therapeutics plc (ITRMF) Change in Acquisitions & Divestments (2017 - 2024)

Iterum Therapeutics has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $1.1 million in Q4 2024.

• On a quarterly basis, Change in Acquisitions & Divestments fell 94.12% year-over-year to $1.1 million in Q4 2024; TTM through Sep 2025 was $1.1 million, a 97.72% decrease from a year earlier, with the FY2024 full-year figure at $30.6 million, down 52.58% from the prior year.
• Change in Acquisitions & Divestments was $1.1 million for Q4 2024 at Iterum Therapeutics, down from $5.7 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $27.3 million in Q2 2023, with the low at $1.1 million in Q4 2024.
• Average Change in Acquisitions & Divestments over 4 years is $12.1 million, with a median of $10.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments soared 464.0% in 2022, then plunged 94.12% in 2024.
• Over 4 years, Change in Acquisitions & Divestments stood at $2.5 million in 2021, then jumped by 464.0% to $14.1 million in 2022, then soared by 32.62% to $18.7 million in 2023, then slumped by 94.12% to $1.1 million in 2024.
• The last three Change in Acquisitions & Divestments figures came in at $1.1 million (Q4 2024), $5.7 million (Q3 2024), and $10.1 million (Q2 2024), per Business Quant data.